Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Clinical Pathology
|
March 30, 2004
A tale of two sisters
D R Gaya, A L C McLay, K A Oien, et al.
QJM : Monthly Journal of the Association of Physicians
|
September 28, 2010
Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding
N Rajoriya, E H Forrest, J Gray, et al.
Alimentary Pharmacology & Therapeutics
|
January 26, 2013
A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease
G D Naismith, L A Smith, S J E Barry, et al.
Lancet (London, England)
|
December 19, 2008
Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation
A J Stanley, D Ashley, H R Dalton, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 10, 2005
Faecal calprotectin in the assessment of Crohn's disease activity
D R Gaya, T D B Lyon, A Duncan, et al.
Alimentary Pharmacology & Therapeutics
|
June 29, 2011
Multicentre comparison of the Glasgow Blatchford and Rockall Scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage
A J Stanley, H R Dalton, O Blatchford, et al.
Alimentary Pharmacology & Therapeutics
|
February 20, 2016
Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
N A Kennedy, B Warner, E L Johnston, et al.
Alimentary Pharmacology & Therapeutics
|
October 7, 2014
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
N A Kennedy, R Kalla, B Warner, et al.
Journal of Crohn'S & Colitis
|
February 16, 2019
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
N Plevris, C S Chuah, R M Allen, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Clinical Pathology
|
March 30, 2004
A tale of two sisters
D R Gaya, A L C McLay, K A Oien, et al.
QJM : Monthly Journal of the Association of Physicians
|
September 28, 2010
Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding
N Rajoriya, E H Forrest, J Gray, et al.
Alimentary Pharmacology & Therapeutics
|
January 26, 2013
A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease
G D Naismith, L A Smith, S J E Barry, et al.
Lancet (London, England)
|
December 19, 2008
Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation
A J Stanley, D Ashley, H R Dalton, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 10, 2005
Faecal calprotectin in the assessment of Crohn's disease activity
D R Gaya, T D B Lyon, A Duncan, et al.
Alimentary Pharmacology & Therapeutics
|
June 29, 2011
Multicentre comparison of the Glasgow Blatchford and Rockall Scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage
A J Stanley, H R Dalton, O Blatchford, et al.
Alimentary Pharmacology & Therapeutics
|
February 20, 2016
Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
N A Kennedy, B Warner, E L Johnston, et al.
Alimentary Pharmacology & Therapeutics
|
October 7, 2014
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
N A Kennedy, R Kalla, B Warner, et al.
Journal of Crohn'S & Colitis
|
February 16, 2019
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
N Plevris, C S Chuah, R M Allen, et al.
Page
of 2